Lithium has been used to treat manic episodes since the 19th century. Though it is widely used, its mechanism of action is still unknown. Lithium carbonate has a narrow therapeutic range and so careful monitoring is required to avoid adverse effects.
Lithium carbonate is indicated as a monotherapy for the treatment of acute manic and mixed episodes associated with bipolar 1 disorder in patients ≥7 years of age. It is also indicated as a maintenance treatment for bipolar 1 disorder in patients ≥7 years of age.
MacLehose Medical Rehabilitation Centre, Pokfulam, Hong Kong SAR, China
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
UCLA, Los Angeles, California, United States
Stanford University - Bipolar Research Program, Palo Alto, California, United States
Lindner Center of HOPE, affliated with University of Cincinnati Medical Center, Mason, Ohio, United States
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
University of Miami Miller School of Medicine, Miami, Florida, United States
University of Miami Miller School of Medicine, Department of Psychiatry, Miami, Florida, United States
ORYGEN Youth Health, PACE Clinic, Parkville, Victoria, Australia
University of Pittsubrgh Medical Center, Pittsburgh, Pennsylvania, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Corella Drug Treatment Service, Fairfield, New South Wales, Australia
University of Pittsburgh/WPIC, Pittsburgh, Pennsylvania, United States
Johns Hopkins Medical Center, Baltimore, Maryland, United States
Children's National Medical Center, Washington, District of Columbia, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.